RepliCel Life Sciences Inc. (RP)’in fiyatı nedir?

RepliCel Life Sciences Inc. (RP)’in fiyatı $0.01100905’dir

RepliCel Life Sciences Inc. (RP)’in piyasa değeri nedir?

RepliCel Life Sciences Inc. (RP)’in piyasa değeri $810.02K’dir.

RepliCel Life Sciences Inc. (RP) Faaliyet Marjı

Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.

Yıl	Faaliyet Marjı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Faaliyet Marjı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Faaliyet Marjı	Faaliyet Marjı Farkı	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	38.97%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR
UCB S.A. UCB.BR	31.23%	-	BE

Şirket

Faaliyet Marjı

Faaliyet Marjı Farkı

Ülke